Syddansk Universitet (University of Southern Denmark)

Research at Syddansk Universitet in Odense focuses on ovarian cancer, especially FIGO stage III disease, with trials designed to assess whether adding new treatment approaches can improve survival after surgery.

• Primary ovarian cancer treatment and outcomes
• Hyperthermic intraperitoneal chemotherapy as an added cancer therapy
• Effectiveness of cytoreductive surgery strategies

This work aims to strengthen treatment results for advanced gynecologic cancers and refine care for patients eligible for major surgical management.

The site also studies migraine and migraine without aura, exploring how symptoms develop in both men and women and testing whether certain medicines can help understand or trigger headache patterns.

• Migraine symptom patterns
• Headache and migraine-like attacks
• Sex-related differences in migraine response

These trials are aimed at improving knowledge of migraine biology and supporting the search for better prevention and treatment approaches.

Clinical research in infectious diseases includes work on Group B streptococcus prevention, with attention to vaccine-related immune responses in pregnant women and healthy participants.

• Group B streptococcus infection prevention
• Vaccine immune response persistence
• Protection for pregnancy and newborn health

The goal is to support better prevention of maternal and neonatal infection through improved understanding of lasting antibody responses.

The trial portfolio at University of Southern Denmark also spans cardiovascular-related and neurovascular questions, using medicines to explore how body signaling pathways may influence headache development.

• cAMP signaling in migraine
• Medicine-induced headache responses
• Potential links between vascular and migraine symptoms

This research helps clarify underlying biological mechanisms and may guide future approaches for more targeted symptom control.